Intelligent Bio Solutions Inc. (INBS) Stock Forecast
INBS analyst forecast
as of October 17, 2026- Analyst consensus
- Strong buy 5.00 / 5 from 1 analysts
- Price target
- $12.00 average of analyst targets
- Upside to target
- +700.0% from the latest close
- Next earnings
- November 11, 2026
- 52-week range
- $1.44 – $17.92
INBS analyst ratings
1 analystsNumber of analysts at each rating.
INBS price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
INBS earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$1.31 | −$1.31 | −$1.31 | — | — | 1 |
| Next quarter (Dec '26) | −$1.36 | −$1.36 | −$1.36 | — | — | 1 |
| Current fiscal year (FY2027) | −$5.18 | −$5.18 | −$5.18 | −$8.44 | +38.6% | 1 |
| Next fiscal year (FY2028) | −$4.06 | −$4.06 | −$4.06 | −$5.18 | +21.6% | 1 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
INBS revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $1.4M | $1.4M | $1.4M | — | 1 |
| Next quarter (Dec '26) | $1.4M | $1.4M | $1.4M | — | 1 |
| Current fiscal year (FY2027) | $6.1M | $6.1M | $6.1M | +44.7% | 1 |
| Next fiscal year (FY2028) | $8.8M | $8.8M | $8.8M | +44.3% | 1 |
INBS EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
INBS revenue: reported and forecast
INBS EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.00 | −$1.31 | −$1.31 | −$1.31 | −$1.31 | — | 0 up · 0 down |
| Next quarter (Dec '26) | $0.00 | −$1.36 | −$1.36 | −$1.36 | −$1.36 | — | 0 up · 0 down |
| Current fiscal year (FY2027) | $0.00 | −$5.18 | −$5.18 | −$5.18 | −$5.18 | — | 0 up · 0 down |
| Next fiscal year (FY2028) | $0.00 | −$4.06 | −$4.06 | −$4.06 | −$4.06 | — | 0 up · 0 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
INBS earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; INBS beat in 3 of 12.
What analysts expect from INBS
1 analysts cover Intelligent Bio Solutions; their consensus rating is strong buy (5.00 on a 1–5 scale, where 5 is a strong buy). The average price target is $12.00, 700.0% above the latest close of $1.50. Analysts expect earnings of −$5.18 per share for FY2027, +38.6% from a year earlier. For FY2028 the average estimate is −$4.06 per share on revenue of $8.8 million. Intelligent Bio Solutions beat the EPS estimate in 3 of the last 12 quarters.
Related: INBS income statement, INBS key metrics, INBS chart. See the INBS stock overview for the latest quote and news.
INBS forecast FAQ
What is Intelligent Bio Solutions's price target?
The average analyst price target for Intelligent Bio Solutions is $12.00, 700.0% above the latest close of $1.50.
Is Intelligent Bio Solutions a buy, hold or sell?
Of 1 analysts covering Intelligent Bio Solutions, 1 rate it a strong buy, 0 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Intelligent Bio Solutions's EPS forecast?
Analysts forecast −$5.18 per share for FY2027 (range −$5.18 to −$5.18); for FY2028 the estimate is −$4.06.
What is Intelligent Bio Solutions's revenue forecast?
The average revenue estimate for FY2027 is $6.1 million, growth of 44.7%; for FY2028 it is $8.8 million.
When does Intelligent Bio Solutions report earnings?
Intelligent Bio Solutions is expected to report results for the quarter ending September 30, 2026 on November 11, 2026.
Does Intelligent Bio Solutions usually beat earnings estimates?
Intelligent Bio Solutions reported EPS at or above the analyst estimate in 3 of the last 12 quarters.